Integra LifeSciences Reports Third Quarter 2017 Financial Results
October 26, 2017 06:00 ET
|
Integra LifeSciences Holdings Corporation
Revenue Increased 11.4% to $279 million; Organic Revenue Increased 1.5% Reported EPS of $0.04; Adjusted EPS of $0.45 PLAINSBORO, N.J., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences...
Integra LifeSciences to Host Third Quarter 2017 Earnings Results Conference Call on October 26, 2017
October 11, 2017 16:30 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., Oct. 11, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will release 2017 third quarter financial...
Integra LifeSciences launches Revize™/ Revize™-X Collagen Matrix for Plastic and Reconstructive Surgery
October 06, 2017 08:30 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., Oct. 06, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced the launch of Revize™ /...
Integra LifeSciences launches SurgiMend® PRS Meshed Collagen Matrix for Plastic and Reconstructive Surgery
October 03, 2017 16:15 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., Oct. 03, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced that it has launched...
Integra LifeSciences Launches Integra® SurgiMend™ PRS Meshed Collagen Matrix for Breast Reconstruction in Europe
October 03, 2017 03:00 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., Oct. 03, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the expansion of its acellular dermal tissue matrix (ADM) product line for...
Integra LifeSciences Completes the Acquisition of Codman Neurosurgery Business from Johnson & Johnson
October 02, 2017 16:00 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., Oct. 02, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a global leader in medical technology, announced today that it has completed the...
Integra LifeSciences Provides Preliminary Assessment of Minor Damage to its Manufacturing Facility in Añasco, Puerto Rico
September 26, 2017 08:00 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., Sept. 26, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that its manufacturing...
Integra LifeSciences Announces First Patient Enrolled in Cadence® Total Ankle System Post-Market Study
September 21, 2017 17:00 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced the first Cadence® Total...
Integra LifeSciences Announces Definitive Agreement to Sell Certain Neurosurgery Assets to Natus Medical Incorporated
September 11, 2017 07:30 ET
|
Integra LifeSciences Holdings Corporation
Natus Medical to acquire global Camino® ICP monitoring product line, U.S. rights to Integra’s fixed pressure shunts, and U.S. rights to Codman’s DURAFORM®, EVD catheters and CSF collection systems ...
Integra LifeSciences to Present at Healthcare Conferences in September 2017
August 17, 2017 16:01 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., Aug. 17, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will present at the Wells Fargo Healthcare...